Reversible lymphoproliferative disorder with isolated lung involvement in a renal transplant patient

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1285-1287

  Al Hawas, Fahad A ^a   Abdalla, Abdalla H ^a   Fedail, Halima ^a   Owda, Ali K ^a   Mousa, Dujanah H ^a   Al Hussaini, Hussa ^a   Al Sulaiman, Mohammed H ^a   Al Khader, Abdullah A ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

Acyclovir; Lung; Post transplant lympho proliferative disorder

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

AGED; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUNG DISEASE; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL;

ACYCLOVIR; AGED; ANTIVIRAL AGENTS; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; LUNG; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 0032916861     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1285     Document Type: Article

References (11)

1. Boubenider SA, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B. Incidence and consequence of post-transplantation lymphoproliferative disorders. J Nephrol 1997; 10: 136-145
2. McCarthy M, Ramage J, Mc-Nair A, Gane E, Portmann B, Pagliuca A, Rela M, Heaton N, Mufti GJ, Williams R. The clinical diversity and role of chemotherapy in lymphoproliferative disorders in liver transplant recipients. Hepatol J 1997; 27: 1015-1021
3. Dusenbery D, Nalesnik MA, Locker J, Swerdlow SH. Cytologic features of post-transplant lymphoproliferative disorders. Diagn Cytopathol 1997; 16: 489-496
4. Senel M, Van Buren C, Riggs S, Clark J, Etheridge W, Kahan B. Post-transplantation lymphoproliferative disorder in the renal transplant ureter. J Urol 1996; 155: 2025
5. Shepherd JD, Gascoyne RD, Barnet MJ, Coghlan JD, Philips GL. Polyclonal Epstein-Bar-virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia. Bone Marrow Transplant 1995; 15: 639-641
6. Egan J, Hasleton Y, Yonan N, Rahman A, Deiraniya A, Carroll K, Woodcock A. Necrotic, ulcerative bronchitis, the presenting feature of lymphoproliferative disease following heart-lung transplantation. Thorax 1995; 50: 205-207
7. Hanto D, Gayl-Peczalska, Frizzera G, Arthur D, Balfour H, McClain K, Simmons R, Najarian J. Epstein-Barr-virus (EBV) induced polyconal and monoconal B-cell lymphoproliferative disease occuring after renal transplantation. Ann Surg 1993; 198:356-369
8. Aris R, Maia D, Neuringer I, Gott K, Kiley S, Gertis K, Handy J. Post-transplantation lymphoproliferative disorder in the Epstein-Barr-virus-naive lung transplant recipient. Am J Respir Crit Care Med 1996; 154: 1712-1717
9. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Prob Surg 1988; 25: 367-372
10. Blancher S, Deist LE, Veder F. Treatment of severe Epstein-Barr-virus-induced polyclonal-B lymphocyte proliferation by anti B-cell monoclonal antibodies: two cases after HLA-mismatched bone marrow transplantation. Ann Int Med 1988; 108: 199-203
11. Fischer A, Blanche S, Le Bidoix J. Anti B-cell monoclonal antibodies in the treatment of severe B-cell-lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991; 324: 1451-1456